Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5646)
All Articles published online
|
Publishing Process of This Article
|
Sep 14, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu ZT, Chen TC, Lu XX, Cheng J, Xie HY, Zhou L, Zheng SS. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients. World J Gastroenterol 2015; 21(34): 10054-10056 [PMID: 26379412 DOI: 10.3748/wjg.v21.i34.10054] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i34/10054.htm |
| Number | Citing Articles |
| 1 |
Irena Míková, Magdaléna Neřoldová, Jaroslav A. Hubáček, Dana Dlouhá, Milan Jirsa, Eva Honsová, Eva Sticová, Věra Lánská, Julius Špičák, Pavel Trunečka. Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation. Transplantation 2020; 104(3): 526 doi: 10.1097/TP.0000000000002876
|
| 2 |
Nader Salari, Niloufar Darvishi, Kamran Mansouri, Hooman Ghasemi, Melika Hosseinian-Far, Fateme Darvishi, Masoud Mohammadi. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. BMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00789-4
|
| 3 |
O. V. Smirnova, D. V. Lagutinskaya. The role of polymorphisms of <I>PNPLA3</I>, <I>MBOAT7</I>, and <I>TM6SF2</I> in the development of non-alcoholic fatty liver disease in metabolic syndrome. Obesity and metabolism 2022; 19(2): 166 doi: 10.14341/omet12855
|
| 4 |
Ahad Eshraghian, Elham Moasser, Negar Azarpira, Mohammad Reza Fattahi, Saman Nikeghbalian, Seyed Ali Malek-Hosseini, Bita Geramizadeh. Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02041-8
|
| 5 |
Guangrong Dai, Pengfei Liu, Xiaomei Li, Xiaoyan Zhou, Shuixiang He. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity. Medicine 2019; 98(7): e14324 doi: 10.1097/MD.0000000000014324
|
| 6 |
Matthew Kappus, Manal Abdelmalek. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation. Clinics in Liver Disease 2017; 21(2): 321 doi: 10.1016/j.cld.2016.12.006
|
| 7 |
Sanjaya K. Satapathy, Quynh T. Tran, Alexander J. Kovalic, Sai Vineela Bontha, Yu Jiang, Satish Kedia, Saradashri Karri, Vamsee Mupparaju, Pradeep S. B. Podila, Rajanshu Verma, Daniel Maluf, Valeria Mas, Satheesh Nair, James D. Eason, Dave Bridges, David E. Kleiner. Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation. Clinical and Translational Gastroenterology 2021; 12(2): e00302 doi: 10.14309/ctg.0000000000000302
|
| 8 |
Pavel Trunečka, Irena Míková, Dana Dlouhá, Jaroslav A. Hubáček, Eva Honsová, Libor Kolesár, Věra Lánská, Soňa Fraňková, Jan Šperl, Milan Jirsa, Rudolf Poledne. Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study. Digestive and Liver Disease 2018; 50(5): 490 doi: 10.1016/j.dld.2017.12.030
|
| 9 |
Yan Xia, Chun-Xia Huang, Guang-Yi Li, Kai-Hua Chen, Li Han, Liang Tang, Huai-qing Luo, Mei-Hua Bao. Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility. Clinics and Research in Hepatology and Gastroenterology 2019; 43(5): 533 doi: 10.1016/j.clinre.2019.01.008
|
| 10 |
M. Shadab Siddiqui, Michael Charlton. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management. Gastroenterology 2016; 150(8): 1849 doi: 10.1053/j.gastro.2016.02.077
|
| 11 |
Hyeyoung Kim, Kwang‐Woong Lee, Kyoungbun Lee, Sooin Seo, Min‐Young Park, Sung Woo Ahn, Suk Kyun Hong, Kyung Chul Yoon, Hyo‐Sin Kim, YoungRok Choi, Hae Won Lee, Nam‐Joon Yi, Kyung‐Suk Suh. Effect of PNPLA3 I148M polymorphism on histologically proven non‐alcoholic fatty liver disease in liver transplant recipients. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12940
|
| 12 |
Danielle Carter, Douglas T. Dieterich, Charissa Chang. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation. Clinics in Liver Disease 2018; 22(1): 213 doi: 10.1016/j.cld.2017.08.015
|
| 13 |
Thomas G. Cotter, Michael Charlton. Nonalcoholic Steatohepatitis After Liver Transplantation. Liver Transplantation 2020; 26(1): 141 doi: 10.1002/lt.25657
|
| 14 |
Natalie H. Bzowej. Nonalcoholic steatohepatitis. Current Opinion in Organ Transplantation 2018; 23(2): 169 doi: 10.1097/MOT.0000000000000502
|
| 15 |
Rosa Lombardi, Giuseppina Pisano, Silvia Fargion, Anna Ludovica Fracanzani. Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Exploration of Medicine 2021; doi: 10.37349/emed.2021.00030
|
| 16 |
Zhengtao Liu, Jun Xu, Shuping Que, Lei Geng, Lin Zhou, Adil Mardinoglu, Shusen Zheng. Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation. Journal of Clinical and Translational Hepatology 2022; 10(2): 363 doi: 10.14218/JCTH.2021.00219
|
| 17 |
Zhengtao Liu, Wenchao Wang, Xiang Li, Junsheng Zhao, Hai Zhu, Shuping Que, Yong He, Jun Xu, Lin Zhou, Adil Mardinoglu, Shusen Zheng. Multi-omics network analysis on samples from sequential biopsies reveals vital role of proliferation arrest for Macrosteatosis related graft failure in rats after liver transplantation. Genomics 2023; 115(6): 110748 doi: 10.1016/j.ygeno.2023.110748
|
| 18 |
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Digestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
|
| 19 |
Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, Amedeo Carraro, Christopher D. Byrne, Giovanni Targher. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation. Nature Reviews Endocrinology 2022; 18(10): 638 doi: 10.1038/s41574-022-00711-5
|
| 20 |
Julia Kozlitina, Naomi M. Cohen, Drew Sturtevant, Jonathan C. Cohen, Cathi Murphey-Half, Jerome G. Saltarrelli, Peter Jindra, Medhat Askar, Christine S. Hwang, Parsia A. Vagefi, Chantale Lacelle, Helen H. Hobbs, Malcolm P. MacConmara. Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort study. eClinicalMedicine 2024; 67: 102350 doi: 10.1016/j.eclinm.2023.102350
|